Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab GTPases constitute the largest family of small monomeric G proteins, encompassing approximately 70 members in humans that act as master regulators of intracellular membrane trafficking [2, 6]. These enzymes function as molecular switches, cycling between an active GTP-bound state associated with specific organelle membranes and an inactive GDP-bound state in the cytosol, a process regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) [3, 10]. By recruiting diverse effector proteins, Rabs coordinate every stage of vesicle transport, including cargo selection, budding, cytoskeletal movement, tethering, and fusion [3, 4, 21]. In disease, Rab dysfunction is a major driver of cancer progression, where specific isoforms like Rab27 and Rab11 facilitate tumor invasion, migration, and the secretion of pro-tumorigenic exosomes [11, 18]. In neurodegenerative disorders such as Parkinson's and Alzheimer's diseases, altered Rab activity (e.g., Rab5, Rab7) leads to impaired protein degradation and autophagic failure [10, 15, 17]. While direct pharmacological targeting is challenging due to the high nucleotide affinity of the GTP-binding pocket, therapeutic strategies currently include inhibitors of post-translational prenylation, modulators of GEF/GAP interactions, and small molecules designed to disrupt Rab-effector protein-protein interactions [4, 16].
Inhibition of guanine nucleotide exchange (GEF blockade), competitive inhibition of effector protein recruitment, or blocking of post-translational C-terminal prenylation required for membrane association [4, 8, 10].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein in brain (Rab GTPase) (Rab).